Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
AstraZeneca
Johnson and Johnson
Colorcon
Mallinckrodt

Last Updated: December 12, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Mafosfamide

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What is the development status for investigational drug Mafosfamide?

Mafosfamide is an investigational drug.

There have been 5 clinical trials for Mafosfamide. The most recent clinical trial was a Phase 1 trial, which was initiated on June 1st 1990.

The most common disease conditions in clinical trials are Meningeal Neoplasms, Nervous System Neoplasms, and Central Nervous System Neoplasms. The leading clinical trial sponsors are National Cancer Institute (NCI), Texas Children's Hospital, and Baylor College of Medicine.

Recent Clinical Trials for Mafosfamide
TitleSponsorPhase
Autologous Peripheral Stem Cell or Bone Marrow Transplant Using Laboratory-Treated Cells in Treating Patients With Acute LeukemiaNational Cancer Institute (NCI)N/A
Autologous Peripheral Stem Cell or Bone Marrow Transplant Using Laboratory-Treated Cells in Treating Patients With Acute LeukemiaSidney Kimmel Comprehensive Cancer CenterN/A
Mafosfamide in Treating Patients With Progressive or Refractory Meningeal TumorsNational Cancer Institute (NCI)Phase 1

See all Mafosfamide clinical trials

Clinical Trial Summary for Mafosfamide

Top disease conditions for Mafosfamide
Top clinical trial sponsors for Mafosfamide

See all Mafosfamide clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Merck
Colorcon
Baxter
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.